Search
for
Sort by
Research 541–570 of 1000+
- Differential diagnosis of trichotillomania by trichoscopy
- Diphencyprone in the treatment of Satoyoshi syndrome
- Meeting report: The 15thannual meeting of the European hair research society
- Hair Today
- Delivery and targeting of nanoparticles into hair follicles
- Gender differences in skin: A review of the literature
- Coat condition, housing condition and measurement of faecal cortisol metabolites - a non-invasive study about alopecia in captive rhesus macaques (Macaca mulatta)
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota
- The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
- The Economic Burden of Alopecia Areata in Romania
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Treatments for alopecia areata: a network meta-analysis
- Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Case of alemtuzumab-related alopecia areata management in MS
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications